Mural Oncology plc
MURA
$2.08
-$0.01-0.48%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -47.98M | -33.14M | -34.27M | -31.76M | -31.56M |
| Total Depreciation and Amortization | 1.14M | 851.00K | 868.00K | 899.00K | 899.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.40M | 417.00K | 1.05M | 438.00K | -1.18M |
| Change in Net Operating Assets | 11.08M | -4.93M | 591.00K | 344.00K | 2.49M |
| Cash from Operations | -31.36M | -36.80M | -31.77M | -30.08M | -29.36M |
| Capital Expenditure | -5.00K | -10.00K | -23.00K | -14.00K | 0.00 |
| Sale of Property, Plant, and Equipment | 780.00K | -- | 67.00K | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1.00M | 28.00M | 36.17M | 19.33M | 43.68M |
| Cash from Investing | 1.78M | 27.99M | 36.21M | 19.31M | 43.68M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00 | 28.00K | 0.00 | 196.00K | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 0.00 | 28.00K | 0.00 | 196.00K | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -29.59M | -8.78M | 4.44M | -10.57M | 14.32M |